Scientific Abstracts (respectively PGA and PhGA) were rated on a 0-10 numeric scale, every 6 months during 2 years then at 3 years. Only patients with all data available for PGA and PhGA for each of the 6 visits were included. Repeated discordance was defined as an absolute difference |PGA-PhGA|≥3/10 for at least 3 of the 6 visits (i.e., at least half of the visits). Univariable and multivariable logistic models were used to determine if repeated discordance was associated at the 3 years timepoint, with prescription of TNFi, functional incapacity defined as HAQ>0.5, and remission defined as ASDAS-CRP<1.3. Results: Of 401 patients, mean age 34.6±8.7 years, mean symptoms duration 17.8±10.7 months, 219 (54.6%) were female and mean ASDAS-CRP at baseline 2.7±1.0. At 3 years 140 (34.9%) patients had been prescribed a TNFi, 172 (43.2%) had HAQ>0.5 and 89 (25.1%) were in remission. Over the 6 visits, mean PGA was higher than mean PhGA with a mean absolute difference of 0.8±2.2 points. Discordance concerned 110 (27.4%) patients at baseline and repeated discordance concerned 92 (22.9%) patients. In multivariable logistic regression, after adjusting on the others significant factors (which included MRI sacro-iliitis, HLA-B27 and ASDAS-CRP at baseline), repeated discordance was associated with more functional incapacity (61% vs 38%, odds ratio, OR 2. Background: Traditionally, radiographic imaging was used to describe morphological differences between various types of axial SpA (axSpA). The advent of MRI has advanced understanding of disease, enabled earlier diagnosis and visualization of structural changes, and facilitated the identification of non-radiographic axial SpA (nr-axSpA). The magnitude of the pathologic changes in the axial skeleton is used to quantify inflammatory and structural outcomes of clinical trials and treatment of patients with axSpA. Objectives: To examine the MRI morphology of sacroiliitis (SI) and vertebral corner lesions in patients with primary (1°, no psoriasis) and secondary (2°, with psoriasis) axSpA. Methods: This posthoc analysis was performed on data from patients with axSpA enrolled in the EMBARK trial (NCT01258738). Only patients with baseline MRI lesions were included. Symmetric and asymmetric SI, structural lesions, and corner inflammatory lesions were analyzed in 1°axSpA vs 2°axSpA patients. Data were analyzed using one-way analysis of variance for continuous parameters, chi-square tests, or Fisher's exact tests for categorical parameters. Results: The baseline demographics and disease characteristics between the 122 patients with 1°axSpA and 19 with 2°axSpA were similar. Asymmetric sacroiliitis was seen in significantly fewer 1°(43%) vs 2°(68%) axSpA patients. There were no differences in mean SpondyloArthritis Research Consortium of
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